Overexpression of DRD2 in patients with gastric cancer had shorter survival durations, and targeting DRD2 by thioridazine significantly inhibited cell proliferation in gastric cancer and reduced cell migration via suppression of EMT related genes in liver cancer (33, 59). This evidence concerns the gene DRD2 and gastric cancer.